Recombinant Danio rerio Malectin is likely produced using methods similar to human MLEC :
Binds Glc₂Man₉GlcNAc₂ (G2M9) N-glycans on misfolded glycoproteins, retaining them in the ER for degradation .
Interacts with ribophorins (OST complex subunits) to mediate ER-associated degradation (ERAD) .
Bacterial binding: Malectin orthologs bind Gram-positive and Gram-negative bacteria via carbohydrate-binding modules (CBMs) .
Antiviral activity: Overexpression reduces viral replication (e.g., VHSV in seahorse models) .
Upregulated in hepatocellular carcinoma (HCC) and promotes tumorigenesis in humans .
SNPs in MLEC correlate with cerebral palsy via macrophage polarization defects .
Functional studies: No direct data on Danio rerio Malectin’s role in zebrafish immunity or development.
Structural analysis: Crystal/NMR structures are unavailable for zebrafish malectin.
Disease models: Role in zebrafish cancer or ER stress responses remains unexplored.
CRISPR/Cas9 knockout models to assess developmental and immune phenotypes.
Glycan microarray assays to map binding specificity.
Comparative studies with human/seahorse malectin to identify conserved mechanisms.